Caristo Diagnostics

Private

OxfordHealthcare & Life Scienceshttps://caristo.com/

Last Round

Series A

Apr 17, 2023

Total Funding Raised

$21.38M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Caristo Diagnostics is a healthtech company that develops AI-powered diagnostic and risk prediction tools for cardiovascular and vascular diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Healthcare Analytics, Medical Devices

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

medical AIcardiovascular imagingcoronary artery diseasecardiac CTcoronary CT angiographyCCTAAI diagnosticsclinical decision supportcoronary inflammationplaque analysiscardiology softwaremedical imaging AIfat attenuation indexFAI-Scorecardiac risk assessmentSaMDsoftware as a medical devicedigital health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Caristo Diagnostics Comps

Public and private peers based on sector, stage, and business model.

Caristo Diagnostics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Caristo Diagnostics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Apr 17, 2023
Grant	Oct 20, 2018
Seed	Oct 20, 2018

View all Funding Rounds

Key People

Founding team and executive leadership

Charalambos Antoniades MD PhD FRCP FMedSci

Founder, Chief Scientific Officer

Founding Team

Caristo Diagnostics Investors

Notable investors and investment history

Caristo Diagnostics investors
Investor	Rounds
BGF	Series A
Oxford Science Enterprises	Seed, Series A
University of Oxford	Series A
Oxford Technology Investment Fund	Seed
OTIF Ventures	Series A
Innovate UK	Grant
Longwall Venture Partners	Seed, Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 14, 2026
Stephen M. Deitsch appointed as new Chief Executive Officer.
Apr 14, 2026
Frank appointed as the new Chief Operating Officer.

View all signals

Caristo Diagnostics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Caristo Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Caristo Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersOxford

Employee Range54

Year Founded2018

Last FundingApr 17, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.